279 related articles for article (PubMed ID: 29695658)
1. Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors.
Nishiwaki K; Ohigashi K; Deguchi T; Murata K; Nakamura S; Matsuda H; Nakanishi I
Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):741-747. PubMed ID: 29695658
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle.
Murata K; Nakao K; Hirata N; Namba K; Nomi T; Kitamura Y; Moriyama K; Shintani T; Iinuma M; Matsuda H
J Nat Med; 2009 Jul; 63(3):355-9. PubMed ID: 19387769
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
[TBL] [Abstract][Full Text] [Related]
6. Coumarin derivatives as promising xanthine oxidase inhibitors.
Fais A; Era B; Asthana S; Sogos V; Medda R; Santana L; Uriarte E; Matos MJ; Delogu F; Kumar A
Int J Biol Macromol; 2018 Dec; 120(Pt A):1286-1293. PubMed ID: 30189275
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Shi A; Zhang L; Wang H; Wang S; Yang M; Guan Q; Bao K; Zhang W
Eur J Med Chem; 2018 Jul; 155():590-595. PubMed ID: 29920453
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.
Zhang TJ; Wu QX; Li SY; Wang L; Sun Q; Zhang Y; Meng FH; Gao H
Bioorg Med Chem Lett; 2017 Aug; 27(16):3812-3816. PubMed ID: 28693909
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase inhibitory activity of isoflavonoids from Apios americana.
Kim JH; Jin CH
Comput Biol Chem; 2019 Dec; 83():107137. PubMed ID: 31639647
[TBL] [Abstract][Full Text] [Related]
12. An in-depth view of potential dual effect of thymol in inhibiting xanthine oxidase activity: Electrochemical measurements in combination with four way PARAFAC analysis and molecular docking insights.
Abbasi S; Gharaghani S; Benvidi A; Rezaeinasab M; Saboury AA
Int J Biol Macromol; 2018 Nov; 119():1298-1310. PubMed ID: 30096398
[TBL] [Abstract][Full Text] [Related]
13. Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors.
Roy S; Narang BK; Gupta MK; Abbot V; Singh V; Rawal RK
Drug Res (Stuttg); 2018 Jul; 68(7):395-402. PubMed ID: 29342493
[TBL] [Abstract][Full Text] [Related]
14. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase inhibitory activity of new pyrrole carboxamide derivatives: In vitro and in silico studies.
Kıbrız İE; Saçmacı M; Yıldırım İ; Abbas Ali Noma S; Taşkın Tok T; Ateş B
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800165. PubMed ID: 30168852
[TBL] [Abstract][Full Text] [Related]
17. Competitive binding experiments can reduce the false positive results of affinity-based ultrafiltration-HPLC: A case study for identification of potent xanthine oxidase inhibitors from Perilla frutescens extract.
Wang Z; Kwon SH; Hwang SH; Kang YH; Lee JY; Lim SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():30-37. PubMed ID: 28192760
[TBL] [Abstract][Full Text] [Related]
18. 4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors.
Shukla S; Kumar D; Ojha R; Gupta MK; Nepali K; Bedi PM
Arch Pharm (Weinheim); 2014 Jul; 347(7):486-95. PubMed ID: 24782427
[TBL] [Abstract][Full Text] [Related]
19. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
